US › Healthcare

YD Bio Ltd (YDES)

US · Healthcare · Biotechnology

$2.32+0.87%
Last close · 2026-08-04

Latest quarter · ended 2025-06-30

Net profit
$-2.2M
Profit YoY
-112.9%
EPS
$-0.65

Key statistics

Market cap
$153.7M
Forward P/E
0.0
P/B
66.53
Book value
$4.57
EPS (TTM)
$-0.12
52-week high
$25.00
52-week low
$1.70
50-day MA
$2.75
200-day MA
$8.07
Beta
-0.13

Shareholding

Insiders
80.13%
Institutions
0.22%

Largest institutional holders

FundStake
Geode Capital Management, LLC0.09%
HPM Partners LLC0.05%
Cypress Capital Management, LLC0.04%
Citadel Advisors Llc0.03%
UBS Group AG0.02%
Wolverine Asset Management LLC0.01%
Morgan Stanley - Brokerage Accounts0.00%
FMR Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for YD Bio Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.